Neurotherapeutics, L.p.

Chicago, IL 60614

SBIR Award Summary

Total Number of Awards 2
Total Value of Awards $0.0
First Award Date 09/30/94
Most Recent Award Date 09/06/99

Key Personnel

Last Name Name Awards Contact
Moskal Joseph Russell Moskal 2

2 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/06/99 - 02/29/00

The N-methyl-D-aspartate (NMDA) receptor appears to be an excellent target for the development of cognitive enhancers. We have generated a monoclonal antibody, B6B21, and have shown that it significantly enhances acquisition rates in hippocampus- dependent trace eyeblink conditioning and acts as a partial agonist at the glycine site of the NMDA...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/94 - 03/30/95

We have generated a monoclonal antibody, B6B21, and have shown that it significantly enhances acquisition rates in hippocampus-dependent trace eyeblink conditioning in rabbits, halving the number of trials required to reach 80% conditioned responses. Previous studies, with a variety of model systems, have shown that B6B21 acts as a partial ago m...